Evidence map›Paper›PMID 36756698›Full record

ArticleAging cell2023

DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice.

Martine de Boer, Maaike Te Lintel Hekkert, Jiang Chang, Bibi S van Thiel, Leonie Martens, Maxime M Bos, Marion G J de Kleijnen, Yanto Ridwan, Yanti Octavia, Elza D van Deel and 21 more

Open access · goldFull text read
In one paragraph

Article in Aging cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. DNA damage and repair in cardiomyopathy: mechanisms and therapeutic opportunities.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Obesity accelerates cardiovascular ageing.European heart journal · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 8 institutions in 4 countries.

Martine de BoerDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0003-3405-654X
Maaike Te Lintel HekkertDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Jiang ChangDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Bibi S van ThielDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Leonie MartensDepartment of Genetic Epidemiology, Institute of Human Genetics, University Hospital Münster, Münster, Germany.
Maxime M BosDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
Marion G J de KleijnenDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Yanto RidwanDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Yanti OctaviaDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Elza D van DeelDepartment of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Lau A BlondenDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Renata M C BrandtDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Sander BarnhoornDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Paula K Bautista-NiñoDivision of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Ilona Krabbendam-PetersDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
Rianne WolswinkelDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Banafsheh ArshiDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
Mohsen GhanbariDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
Christian KupattI. Medizinische Klinik und Poliklinik, University Clinic Rechts der Isar, Technical University of Munich, Munich, Germany.
Leon J de WindtDepartment of Molecular Genetics, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
A H Jan DanserDivision of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Ingrid van der PluijmDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Carol Ann RemmeDepartment of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Monika StollDepartment of Genetic Epidemiology, Institute of Human Genetics, University Hospital Münster, Münster, Germany.
Joris PothofDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Anton J M RoksDivision of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Maryam KavousiDepartment of Epidemiology, Erasmus MC, Rotterdam, The Netherlands.
Jeroen EssersDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Jolanda van der VeldenDepartment of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Jan H J HoeijmakersDepartment of Molecular Genetics, Erasmus MC, Rotterdam, The Netherlands.
Dirk J DunckerDivision of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0003-2836-2241
Erasmus MC · NLAmsterdam UMC Location University of Amsterdam · NLMaastricht University · NLAmsterdam University Medical Centers · NLNetherlands Heart Institute · NLTUM Klinikum · DEUniversity Hospital Münster · DEUniversity of Cologne · DE

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
NIA NIH HHS P01 AG017242
6 · The paper itself

Abstract

Heart failure has reached epidemic proportions in a progressively ageing population. The molecular mechanisms underlying heart failure remain elusive, but evidence indicates that DNA damage is enhanced in failing hearts. Here, we tested the hypothesis that endogenous DNA repair in cardiomyocytes is critical for maintaining normal cardiac function, so that perturbed repair of spontaneous DNA damage drives early onset of heart failure. To increase the burden of spontaneous DNA damage, we knocked out the DNA repair endonucleases xeroderma pigmentosum complementation group G (XPG) and excision repair cross-complementation group 1 (ERCC1), either systemically or cardiomyocyte-restricted, and studied the effects on cardiac function and structure. Loss of DNA repair permitted normal heart development but subsequently caused progressive deterioration of cardiac function, resulting in overt congestive heart failure and premature death within 6 months. Cardiac biopsies revealed increased oxidative stress associated with increased fibrosis and apoptosis. Moreover, gene set enrichment analysis showed enrichment of pathways associated with impaired DNA repair and apoptosis, and identified TP53 as one of the top active upstream transcription regulators. In support of the observed cardiac phenotype in mutant mice, several genetic variants in the ERCC1 and XPG gene in human GWAS data were found to be associated with cardiac remodelling and dysfunction. In conclusion, unrepaired spontaneous DNA damage in differentiated cardiomyocytes drives early onset of cardiac failure. These observations implicate DNA damage as a potential novel therapeutic target and highlight systemic and cardiomyocyte-restricted DNA repair-deficient mouse mutants as bona fide models of heart failure.

Indexed as

DNA-Binding ProteinsHeart FailureAnimalsDNA DamageDNA RepairEndonucleasesHumansMiceMyocytes, CardiacXeroderma PigmentosumDNA-Binding ProteinsEndonucleasesapoptosiscardiac functioncongestive heart failureDNA damageDNA repair

Identifiers

PMID36756698
PMCPMC10014058
OpenAlexW4319656390

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.